Aurique board meet Aug 6, 2026 to weigh fund raise

What the August 06 board meeting is about

Aurique Limited said its Board of Directors will meet on August 06, 2026 to consider a proposal to raise funds. The company indicated the fund raise may be structured through equity shares, warrants, or other convertible securities. It also outlined multiple issuance routes, including rights issues and placements. The stated issuance modes include rights issue, preferential allotment and private placement.

Any decision at the board level will still require shareholder approval. The company said the proposal is subject to approval at an Extra-Ordinary General Meeting (EGM). It will also need relevant regulatory clearances in line with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Instruments and issuance routes under consideration

The company’s disclosure highlights flexibility in the choice of instruments. It explicitly lists equity shares, warrants and convertible securities as possible instruments. On issuance method, it points to rights issue and placement-based routes.

Rights issues typically involve offering new shares to existing shareholders, while preferential allotment and private placements allow the company to allot securities to identified investors, subject to applicable rules and approvals. The final structure, pricing and investor categories were not detailed in the provided information. The company, however, made it clear that shareholder approval and regulatory compliances will be required before any allotment.

Shareholder and regulatory approvals: what is explicitly required

Aurique has linked the proposed capital-raising plan to shareholder approval via an EGM. It also referenced regulatory clearances required under SEBI LODR Regulations. This generally covers disclosure obligations, governance processes and stock exchange-related compliances for listed entities.

Because the company has not yet disclosed the size of the proposed fund raise for the August 06, 2026 meeting, investors will likely track what resolutions are placed before shareholders and what approvals are sought from exchanges or regulators after the board meeting.

Background: PAE’s February 2026 restructuring and the Aurique rebrand

The fund-raise proposal comes after a wider corporate restructuring that was approved earlier in 2026 when the entity was referred to as PAE Limited. The PAE board approved extensive restructuring on February 06, 2026.

As part of that package, the company approved an increase in authorised capital to INR 27.48 crore. It also approved preferential issues with an aggregate value of INR 158.85 crore, a registered office relocation to Ahmedabad, and enhanced borrowing and investment limits of INR 5,000 crore each. The board also approved the appointment of a new CFO, Mr. Pinalkumar Kalidas Patel.

The name change from PAE Limited to Aurique Limited was also part of the restructuring path. The company stated that approval for the name change was received from the Central Registration Centre on January 09, 2026.

Details of the INR 158.85 crore preferential issues approved in February 2026

The February 06, 2026 board actions included two major preferential issues totalling INR 158.85 crore. Both were priced at INR 60 per equity share, as per the provided figures. The first component involved issuing up to 800,000 equity shares by way of conversion of loan into equity, amounting to INR 4.80 crore. The second component involved issuing up to 25,674,993 equity shares by way of swap of shares, amounting to about INR 154.05 crore.

The combined share count for these two components was stated as 26,474,993 equity shares.

Earlier preferential allotment and warrants: September 2024 actions

The company also disclosed an earlier preferential allotment process linked to a members’ EGM held on August 24, 2024, and in-principle approvals received from NSE and BSE on September 12, 2024. Following these approvals, the board meeting on September 21, 2024 approved two allotments.

First, the allotment of 3,439,000 equity shares of face value INR 10 each at an issue price of INR 83.75 per share, aggregating to about INR 28.80 crore, to persons in the non-promoter public category on a preferential basis for cash. Second, the allotment of 5,096,000 fully convertible warrants at an issue price of INR 83.75 per warrant, aggregating to about INR 42.68 crore, with an upfront receipt of 25 percent amounting to about INR 10.67 crore.

Following the equity share allotment, the company stated its paid-up equity share capital increased to about INR 16.07 crore, comprising 160,72,900 equity shares of face value INR 10 each. It also clarified that the allotment of convertible warrants did not change paid-up share capital at that time.

Warrants and conversions disclosed in later updates

Separate disclosures in the provided text also cover additional preferential warrant and equity issuances and conversions. One item mentions an approved issue and allotment of up to 2,325,918 fully convertible warrants at an issue price of INR 270 per warrant, aggregating to about INR 62.80 crore, convertible within 18 months from the date of allotment, subject to shareholder and statutory approvals.

Another item mentions a preferential issue of 107,963 equity shares at an issue price of INR 270 per share, aggregating to about INR 2.92 crore, to named non-promoter allottees, subject to member and regulatory approvals.

The text also includes two conversion-related disclosures. In one, the board approved allotment of 4,393,592 equity shares pursuant to conversion of 4,393,592 warrants at an issue price of INR 369 per share and receipt of balance consideration aggregating to about INR 79.52 crore. In another, the board approved allotment of 185,900 equity shares on conversion of 185,900 warrants at an issue price of INR 747 per share after receipt of balance amount aggregating to about INR 10.42 crore, and stated that paid-up equity capital increased from about INR 3.61 crore to about INR 3.80 crore.

Market impact: what investors can infer from the disclosed facts

The immediate market relevance of the August 06, 2026 meeting is that Aurique is considering another capital-raising step, with multiple instrument choices and issuance routes. While the company has not disclosed the targeted fund-raise amount for this meeting, it has explicitly positioned the decision as subject to shareholder approval and SEBI LODR-related clearances.

The broader context is that the company has used several capital-market tools in the past, including preferential allotments, warrants, and warrant conversions, and has also approved a large preferential issue package in 2026 totalling INR 158.85 crore. Any fresh issuance, depending on final structure, can change the capital base, but the exact impact cannot be quantified without the proposed size, pricing, and instrument terms.

Key milestones mentioned in disclosures

What to watch next

The next concrete update will be what the board decides on August 06, 2026, including the chosen instrument, issuance route, and whether it proceeds to seek shareholder approval via an EGM. Subsequent filings, including any EGM notice and outcome, will clarify the resolutions, the proposed issue size, and the approvals being pursued.

For now, the company’s disclosures establish only the intent to evaluate a fund raise and the approval pathway it must follow under shareholder voting and regulatory processes.